CRTx® Daily Return Summary *
CRTx® Daily Return Summary *
September 2021 Month-End CRTx® Index Rebalancing Update
August 2021 Month-End CRTx® Index Rebalancing Update
July 2021 Month-End CRTx® Index Rebalancing Update
June 2021 Month-End CRTx® Index Rebalancing Update
SCI's 1st Annual CLO Special Opportunities Seminar 2021
IMN's Virtual Investor Conference on Risk Transfer
May 2021 Month-End CRTx® Index Rebalancing Update
April 2021 Month-End CRTx® Index Rebalancing Update
* MF & Co Named SCI Capital Relief Trades Awards 2020 Winner:
ANALYTICS FIRM OF THE YEAR
UPCOMING: MF&Co Chief Strategist Mark Fontanilla to speak at
SCI's 1st ANNUAL CLO SPECIAL OPPORTUNITIES SEMINAR
Conference Panel: "Middle Market CLOs"
Tuesday 6/29/2021
12:10pm EST
-
Offering a wider spread advantage to their BSL siblings how is the more opaque sector really faring now the initial stage of the Covid crisis is behind us, but the true economic impact is still ahead, and do MM CLOs still offer enough reward for the risk?
-
How attractive are risk adjusted returns for MM CLOs, what are the challenges in analysing the credits given the private/bilateral nature of loans?
Advanced Market Intelligence, Insights, and Strategies
Providing Comprehensive Strategic Consulting and Advisory Services To The Markets
LATEST CRTx® Index Rebalancing Metrics (10/1/2021)
CRTx® Index Basket: Sep 2021 Factor Updates (9/27/2021)
-
September CRTx® AGG paydown percentage increased vs August with FHLMC’s tender offer and more deals passing DQ tests.
-
$2.4 billion in paydowns/tenders (vs $865M paydowns in Aug)
-
Class C/Es incrementally higher across the board.
-
Both tranche and reference pool realized write-downs/shortfalls remained nominal.
-
September factor speeds sideways/incrementally higher based on STACR.
-
Total DQ% mostly lower, 180+ DQ #/$ continue to trend lower sector-wide.
-
62 reference pool groups continued to fail their DQ Test in September, down six vs. 68 in August
CONTACT INFO:
Mark Fontanilla & Co., LLC
255 W MLK Blvd Ste. 2402
Charlotte, NC 28202
O: 704-405-0575
C: 201-213-7168